Annual EBITDA
-$6.13 M
+$2.33 M+27.52%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual EBITDA is -$6.13 million, with the most recent change of +$2.33 million (+27.52%) on September 30, 2024.
- During the last 3 years, EDSA annual EBITDA has risen by +$7.09 million (+53.63%).
- EDSA annual EBITDA is now -8195.53% below its all-time high of -$73.90 thousand, reached on April 30, 2009.
Performance
EDSA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$923.00 K
+$721.80 K+43.88%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly EBITDA is -$923.00 thousand, with the most recent change of +$721.80 thousand (+43.88%) on September 30, 2024.
- Over the past year, EDSA quarterly EBITDA has increased by +$948.10 thousand (+50.67%).
- EDSA quarterly EBITDA is now -173.22% below its all-time high of $1.26 million, reached on August 31, 2011.
Performance
EDSA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$6.13 M
+$819.70 K+11.79%
September 30, 2024
Summary
- As of February 12, 2025, EDSA TTM EBITDA is -$6.13 million, with the most recent change of +$819.70 thousand (+11.79%) on September 30, 2024.
- Over the past year, EDSA TTM EBITDA has increased by +$1.16 million (+15.87%).
- EDSA TTM EBITDA is now -13993.10% below its all-time high of -$43.50 thousand, reached on October 31, 2009.
Performance
EDSA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EDSA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.5% | +50.7% | +15.9% |
| 3 y3 years | +53.6% | +53.4% | +35.6% |
| 5 y5 years | -116.8% | +53.4% | +35.6% |
EDSA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.9% | at high | +84.0% | at high | +66.4% |
| 5 y | 5-year | -116.8% | +64.9% | at high | +84.0% | -25.0% | +66.4% |
| alltime | all time | -8195.5% | +64.9% | -173.2% | +84.0% | <-9999.0% | +66.4% |
Edesa Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$6.13 M(-27.5%) | -$923.00 K(-43.9%) | -$6.13 M(-11.8%) |
| Jun 2024 | - | -$1.64 M(-12.1%) | -$6.95 M(-4.6%) |
| Mar 2024 | - | -$1.87 M(+10.6%) | -$7.29 M(-6.6%) |
| Dec 2023 | - | -$1.69 M(-2.9%) | -$7.80 M(-7.8%) |
| Sep 2023 | -$8.46 M(-51.6%) | -$1.74 M(-12.0%) | -$8.46 M(-11.2%) |
| Jun 2023 | - | -$1.98 M(-16.9%) | -$9.52 M(-28.5%) |
| Mar 2023 | - | -$2.38 M(+1.4%) | -$13.31 M(-14.0%) |
| Dec 2022 | - | -$2.35 M(-16.3%) | -$15.47 M(-11.5%) |
| Sep 2022 | -$17.47 M(+32.1%) | -$2.81 M(-51.3%) | -$17.47 M(-4.3%) |
| Jun 2022 | - | -$5.77 M(+26.9%) | -$18.26 M(+6.0%) |
| Mar 2022 | - | -$4.55 M(+4.5%) | -$17.22 M(+14.9%) |
| Dec 2021 | - | -$4.35 M(+21.1%) | -$14.99 M(+13.4%) |
| Sep 2021 | -$13.22 M(+108.4%) | -$3.59 M(-24.1%) | -$13.22 M(+13.9%) |
| Jun 2021 | - | -$4.73 M(+104.9%) | -$11.61 M(+34.7%) |
| Mar 2021 | - | -$2.31 M(-10.6%) | -$8.62 M(+10.2%) |
| Dec 2020 | - | -$2.58 M(+30.5%) | -$7.83 M(+23.4%) |
| Sep 2020 | -$6.34 M(+124.4%) | -$1.98 M(+13.6%) | -$6.34 M(+19.0%) |
| Jun 2020 | - | -$1.74 M(+15.3%) | -$5.33 M(+8.7%) |
| Mar 2020 | - | -$1.51 M(+37.2%) | -$4.91 M(-2.7%) |
| Dec 2019 | - | -$1.10 M(+13.9%) | -$5.04 M(-4.9%) |
| Sep 2019 | -$2.83 M(-42.2%) | -$968.30 K(-26.7%) | -$5.30 M(-3.1%) |
| Jun 2019 | - | -$1.32 M(-19.9%) | -$5.47 M(+4.0%) |
| Mar 2019 | - | -$1.65 M(+21.0%) | -$5.26 M(+7.1%) |
| Dec 2018 | - | -$1.36 M(+19.4%) | -$4.91 M(+0.4%) |
| Sep 2018 | -$4.89 M(-3.1%) | -$1.14 M(+2.6%) | -$4.89 M(-3.6%) |
| Jun 2018 | - | -$1.11 M(-14.3%) | -$5.07 M(-2.6%) |
| Mar 2018 | - | -$1.30 M(-3.2%) | -$5.21 M(+3.9%) |
| Dec 2017 | - | -$1.34 M(+1.2%) | -$5.02 M(-0.6%) |
| Sep 2017 | -$5.05 M(+6.0%) | -$1.33 M(+6.1%) | -$5.05 M(+1.0%) |
| Jun 2017 | - | -$1.25 M(+13.3%) | -$4.99 M(+2.0%) |
| Mar 2017 | - | -$1.10 M(-19.5%) | -$4.90 M(+0.9%) |
| Dec 2016 | - | -$1.37 M(+7.5%) | -$4.85 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | -$4.76 M(+13.9%) | -$1.27 M(+10.7%) | -$4.76 M(+8.3%) |
| Jun 2016 | - | -$1.15 M(+8.6%) | -$4.39 M(+7.8%) |
| Mar 2016 | - | -$1.06 M(-16.9%) | -$4.08 M(-2.2%) |
| Dec 2015 | - | -$1.27 M(+40.4%) | -$4.17 M(-0.3%) |
| Sep 2015 | -$4.18 M(+850.2%) | -$907.80 K(+8.9%) | -$4.18 M(-7.1%) |
| Jun 2015 | - | -$833.80 K(-27.5%) | -$4.50 M(-9.7%) |
| Mar 2015 | - | -$1.15 M(-10.7%) | -$4.98 M(-4.7%) |
| Dec 2014 | - | -$1.29 M(+5.1%) | -$5.23 M(-6.0%) |
| Sep 2014 | -$439.80 K(-92.1%) | - | - |
| Aug 2014 | -$5.56 M(+49.3%) | -$1.23 M(-7.1%) | -$5.56 M(-0.9%) |
| May 2014 | - | -$1.32 M(-5.5%) | -$5.61 M(+11.1%) |
| Feb 2014 | - | -$1.40 M(-13.8%) | -$5.05 M(+12.9%) |
| Nov 2013 | - | -$1.62 M(+27.2%) | -$4.47 M(+20.0%) |
| Aug 2013 | -$3.72 M(-42.1%) | -$1.27 M(+68.0%) | -$3.72 M(-10.7%) |
| May 2013 | - | -$758.20 K(-7.3%) | -$4.17 M(-16.7%) |
| Feb 2013 | - | -$817.70 K(-6.4%) | -$5.00 M(-10.3%) |
| Nov 2012 | - | -$873.50 K(-49.2%) | -$5.58 M(-13.3%) |
| Aug 2012 | -$6.43 M(+35.6%) | -$1.72 M(+7.8%) | -$6.43 M(+86.2%) |
| May 2012 | - | -$1.59 M(+14.3%) | -$3.46 M(+9.1%) |
| Feb 2012 | - | -$1.39 M(-19.4%) | -$3.17 M(-44.3%) |
| Nov 2011 | - | -$1.73 M(-237.2%) | -$5.69 M(+19.9%) |
| Aug 2011 | -$4.74 M(+730.3%) | $1.26 M(-196.7%) | -$4.74 M(-23.0%) |
| May 2011 | - | -$1.30 M(-66.7%) | -$6.16 M(+18.7%) |
| Feb 2011 | - | -$3.92 M(+398.5%) | -$5.19 M(+303.4%) |
| Nov 2010 | - | -$785.40 K(+408.0%) | -$1.29 M(+139.1%) |
| Aug 2010 | -$571.40 K(+673.2%) | -$154.60 K(-53.9%) | -$538.10 K(+40.3%) |
| May 2010 | - | -$335.50 K(+2869.0%) | -$383.50 K(+677.9%) |
| Jan 2010 | - | -$11.30 K(-69.2%) | -$49.30 K(+13.3%) |
| Oct 2009 | - | -$36.70 K(+2723.1%) | -$43.50 K(-40.5%) |
| Apr 2009 | -$73.90 K | -$1300.00(-76.4%) | -$73.10 K(+1.8%) |
| Jan 2009 | - | -$5500.00(-91.7%) | -$71.80 K(+8.3%) |
| Oct 2008 | - | -$66.30 K | -$66.30 K |
FAQ
- What is Edesa Biotech annual EBITDA?
- What is the all time high annual EBITDA for Edesa Biotech?
- What is Edesa Biotech annual EBITDA year-on-year change?
- What is Edesa Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Edesa Biotech?
- What is Edesa Biotech quarterly EBITDA year-on-year change?
- What is Edesa Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for Edesa Biotech?
- What is Edesa Biotech TTM EBITDA year-on-year change?
What is Edesa Biotech annual EBITDA?
The current annual EBITDA of EDSA is -$6.13 M
What is the all time high annual EBITDA for Edesa Biotech?
Edesa Biotech all-time high annual EBITDA is -$73.90 K
What is Edesa Biotech annual EBITDA year-on-year change?
Over the past year, EDSA annual EBITDA has changed by +$2.33 M (+27.52%)
What is Edesa Biotech quarterly EBITDA?
The current quarterly EBITDA of EDSA is -$923.00 K
What is the all time high quarterly EBITDA for Edesa Biotech?
Edesa Biotech all-time high quarterly EBITDA is $1.26 M
What is Edesa Biotech quarterly EBITDA year-on-year change?
Over the past year, EDSA quarterly EBITDA has changed by +$948.10 K (+50.67%)
What is Edesa Biotech TTM EBITDA?
The current TTM EBITDA of EDSA is -$6.13 M
What is the all time high TTM EBITDA for Edesa Biotech?
Edesa Biotech all-time high TTM EBITDA is -$43.50 K
What is Edesa Biotech TTM EBITDA year-on-year change?
Over the past year, EDSA TTM EBITDA has changed by +$1.16 M (+15.87%)